Literature DB >> 23358708

Inflammatory responses to hepatitis B virus vaccine in healthy term infants.

Istemi Han Celik1, Gamze Demirel, Fuat Emre Canpolat, Omer Erdeve, Ugur Dilmen.   

Abstract

UNLABELLED: Hepatitis B virus (HBV) infection continues to be a serious global health problem. During the course of HBV vaccination, we observed C-reactive protein (CRP) elevation in term infants without sepsis. Therefore, we prospectively studied interleukin-6 (IL-6) and CRP responses to HBV immunization. In 70 healthy term infants without signs and symptoms of sepsis and sepsis risk factors, IL-6, CRP, and white blood cell count levels were determined before and 24 h after immunization. Significant increases in CRP levels were seen 24 h after vaccination (p < 0.001). Although CRP levels of 22 infants at second evaluation were above the cutoff level for sepsis (4.82 mg/L), they had no clinical signs and symptoms of sepsis. After 48-72 h, CRP levels of these infants returned to normal levels with no blood culture positivity.
CONCLUSION: our study showed that HBV vaccine is responsible for CRP elevation in term infants after vaccination at birth. To the best of our knowledge, this is the first study evaluating CRP response to HBV vaccine at birth in term infants. We suggest that this response should be considered in differentiation of early neonatal sepsis to avoid unnecessary antibiotic use.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23358708     DOI: 10.1007/s00431-013-1946-2

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  13 in total

1.  Procalcitonin and C-reactive protein in vaccination-associated adverse reactions.

Authors:  Bartosz Korczowski
Journal:  Pediatr Infect Dis J       Date:  2004-03       Impact factor: 2.129

2.  CRP as a predictive of neonatal sepsis and its role in differentiating the aetiologies.

Authors:  Omer Erdeve; Istemi Han Celik; Nurdan Uras; Fatma Gamze Demirel; Serife Suna Oguz; Ugur Dilmen
Journal:  Acta Paediatr       Date:  2010-10-25       Impact factor: 2.299

3.  Interleukin-6, C-reactive protein, and abnormal cardiorespiratory responses to immunization in premature infants.

Authors:  M Pourcyrous; S B Korones; D Crouse; H S Bada
Journal:  Pediatrics       Date:  1998-03       Impact factor: 7.124

4.  Immunisation and C reactive protein in infants on neonatal intensive care units.

Authors:  D R Balkundi; J A Nycyk; R W Cooke
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-09       Impact factor: 5.747

5.  What are the cut-off levels for IL-6 and CRP in neonatal sepsis?

Authors:  Istemi Han Celik; Fatma Gamze Demirel; Nurdan Uras; Serife Suna Oguz; Omer Erdeve; Zeynep Biyikli; Ugur Dilmen
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

6.  Seven-year follow-up of vaccine response in extremely premature infants.

Authors:  Khaver I Kirmani; Geraldine Lofthus; Michael E Pichichero; Timothy Voloshen; Carl T D'Angio
Journal:  Pediatrics       Date:  2002-03       Impact factor: 7.124

Review 7.  Recombivax-HB: perspectives past, present and future.

Authors:  Charmaine Venters; William Graham; William Cassidy
Journal:  Expert Rev Vaccines       Date:  2004-04       Impact factor: 5.217

Review 8.  Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B.

Authors:  Gillian M Keating; Stuart Noble
Journal:  Drugs       Date:  2003       Impact factor: 9.546

9.  Primary immunization of premature infants with gestational age <35 weeks: cardiorespiratory complications and C-reactive protein responses associated with administration of single and multiple separate vaccines simultaneously.

Authors:  Massroor Pourcyrous; Sheldon B Korones; Kristopher L Arheart; Henrietta S Bada
Journal:  J Pediatr       Date:  2007-06-22       Impact factor: 4.406

10.  Benefits of early hepatitis B immunization programs for newborns and infants.

Authors:  Koen Van Herck; Pierre Van Damme
Journal:  Pediatr Infect Dis J       Date:  2008-10       Impact factor: 2.129

View more
  7 in total

1.  Impact and interactions between risk factors on the iron status of at-risk neonates.

Authors:  Christine E Brichta; Jennie Godwin; Sally Norlin; Pamela J Kling
Journal:  J Perinatol       Date:  2022-02-07       Impact factor: 3.225

2.  C-reactive protein levels following hepatitis B vaccine in healthy newborns.

Authors:  F Dapaah-Siakwan; A Gunasekaran; D L Schutzman
Journal:  J Perinatol       Date:  2015-11-12       Impact factor: 2.521

3.  Unique Inflammatory Mediators and Specific IgE Levels Distinguish Local from Systemic Reactions after Anthrax Vaccine Adsorbed Vaccination.

Authors:  Lori Garman; Kenneth Smith; Emily E Muns; Cathy A Velte; Christina E Spooner; Melissa E Munroe; A Darise Farris; Michael R Nelson; Renata J M Engler; Judith A James
Journal:  Clin Vaccine Immunol       Date:  2016-08-05

Review 4.  Diagnostic and Prognostic Value of Monocyte Distribution Width in Sepsis.

Authors:  Juehui Wu; Laisheng Li; Jinmei Luo
Journal:  J Inflamm Res       Date:  2022-07-20

Review 5.  Potential Use of Salivary Markers for Longitudinal Monitoring of Inflammatory Immune Responses to Vaccination.

Authors:  Pei Wen Lim; Johan Garssen; Elena Sandalova
Journal:  Mediators Inflamm       Date:  2016-02-28       Impact factor: 4.711

6.  Predictors of serious bacterial infections using serum biomarkers in an infant population aged 0 to 90 days: a prospective cohort study.

Authors:  Serena Su Ying Chang; Amanda Zhirui Lim; Gene Yong-Kwang Ong; Rupini Piragasam; John Carson Allen; Kee Chong Ng; Ian Maconochie; Shu-Ling Chong
Journal:  BMJ Paediatr Open       Date:  2021-01-20

Review 7.  Diagnosis of neonatal sepsis: the past, present and future.

Authors:  Istemi Han Celik; Morcos Hanna; Fuat Emre Canpolat
Journal:  Pediatr Res       Date:  2021-11-02       Impact factor: 3.756

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.